Why sepsis trials fail

被引：168

作者：

Bone, RC

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 276卷 / 07期

关键词：

D O I：

10.1001/jama.276.7.565

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：565 / 566

页数：2

共 29 条

[1] EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].

ABRAHAM, E ;

WUNDERINK, R ;

SILVERMAN, H ;

PERL, TM ;

NASRAWAY, S ;

LEVY, H ;

BONE, R ;

WENZEL, RP ;

BALK, R ;

ALLRED, R ;

PENNINGTON, JE ;

WHERRY, JC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941

[2] A 2ND LARGE CONTROLLED CLINICAL-STUDY OF E5, A MONOCLONAL-ANTIBODY TO ENDOTOXIN - RESULTS OF A PROSPECTIVE, MULTICENTER, RANDOMIZED, CONTROLLED TRIAL [J].

BONE, RC ;

BALK, RA ;

FEIN, AM ;

PERL, TM ;

WENZEL, RP ;

REINES, HD ;

QUENZER, RW ;

IBERTI, TJ ;

MACINTYRE, N ;

SCHEIN, RMH ;

TRENHOLME, G ;

NIEDERMAN, M ;

CHALFIN, D ;

ABALOS, A ;

OROPELLO, J ;

EMPSON, P ;

CAMINITII, S ;

GREENMAN, R ;

BOOTH, F ;

PLOUFFE, J ;

RUSSELL, J ;

GIANAKOPOULOS, G ;

IANNINI, P ;

HINDES, R ;

COBLENS, K ;

KOHLER, R ;

MARTIN, M ;

BERNARD, G ;

EDWARDS, J ;

CRISLIP, M ;

FILLER, S ;

NASRAWAY, SA ;

SIGEL, PK ;

SOTTILE, FD ;

MARTIN, DH ;

DEBOISBLANC, BP ;

CHANDRASEKAR, PH ;

BROUGHTON, WA ;

MIDDLETON, RM ;

SEIBERT, AF ;

EMMANUEL, G ;

LIE, TH ;

ANDERSON, CLV ;

PANKEY, GA ;

ANDERSON, P ;

OLSEN, K ;

SANPEDRO, GS ;

GRAHAM, D ;

GROSSMAN, J ;

WELS, PB .

CRITICAL CARE MEDICINE, 1995, 23 (06) :994-1006

[3] A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].

BONE, RC ;

FISHER, CJ ;

CLEMMER, TP ;

SLOTMAN, GJ ;

METZ, CA ;

BALK, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658

[4] Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation [J].

Bone, RC .

CRITICAL CARE MEDICINE, 1996, 24 (01) :163-172

[5]

BRUNET F, 1995, AM J RESP CRIT CARE, V151, P1269

[6]

CARLET, 1995, CURR OPIN CRIT CARE, V1, P349

[7] PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].

CASEY, LC ;

BALK, RA ;

BONE, RC .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778

[8] NEUTROPHIL FUNCTION IN SURGICAL PATIENTS - 2 INHIBITORS OF GRANULOCYTE CHEMOTAXIS ASSOCIATED WITH SEPSIS [J].

CHRISTOU, NV ;

MEAKINS, JL .

JOURNAL OF SURGICAL RESEARCH, 1979, 26 (04) :355-364

[9] PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL-TRIAL [J].

DHAINAUT, JFA ;

TENAILLON, A ;

LETULZO, Y ;

SCHLEMMER, B ;

SOLET, JP ;

WOLFF, M ;

HOLZAPFEL, L ;

ZENI, F ;

DREYFUSS, D ;

MIRA, JP ;

DEVATHAIRE, F ;

GUINOT, P .

CRITICAL CARE MEDICINE, 1994, 22 (11) :1720-1728

[10]

FAIST E, 1992, SURGERY, V112, P562

← 1 2 3 →